BioMarck Pharmaceuticals' Series D Round

BioMarck Pharmaceuticals raised a round of funding on May 18, 2016.

BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of …

Articles about BioMarck Pharmaceuticals' Series D Round: